logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Dawnrays Pharmaceutical (02348.HK) repurchased 232,000 shares for HKD 213,600 on November 2.

date
02/11/2026
Zhitong Finance APP News, Dawnrays Pharmaceutical (02348.HK) announced that on November 2, 2026, the company spent HK$213,600 to repurchase 232,000 shares at a repurchase price of HK$0.915-0.925 per share.
Latest
3 m ago
Marvell Technology (MRVL.O) has reached an agreement to acquire data center optical equipment maker Lumentum Holdings at an enterprise value of $115 billion, one of the largest deals in tech industry history, reflecting companies' race to seize the opportunities presented by the AI boom. According to a joint statement, the all-stock transaction will leave Marvell shareholders owning 67% of the combined company. Bloomberg had previously reported that the two Silicon Valley companies were nearing the mega-deal. Data shows that by equity value, this would be the largest M&A deal of the year and the largest ever in the global tech industry, excluding the SpaceX-xAI merger. The deal illustrates how the AI boom is driving M&A activity across nearly all major industries and regions, involving chipmakers, specialized technology suppliers, data center operators, and electric utility companies.
5 m ago
Travel demand remains resilient! Marriott (MAR.US) Q3 profit and RevPAR beat expectations, raises full-year outlook.
9 m ago
IDEXX shares rise 6.5% premarket after it forecasts full-year revenue above expectations.
9 m ago
Citi: Raises AbbVie (ABBV.N) price target from $260 to $295.
9 m ago
Citigroup raises AbbVie price target to $295 from $260.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.